These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4031029)

  • 1. Occurrence of Streptococcus milleri among beta-hemolytic streptococci isolated from clinical specimens.
    Ruoff KL; Kunz LJ; Ferraro MJ
    J Clin Microbiol; 1985 Aug; 22(2):149-51. PubMed ID: 4031029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci.
    Lawrence J; Yajko DM; Hadley WK
    J Clin Microbiol; 1985 Nov; 22(5):772-7. PubMed ID: 3902878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rapid carbohydrate utilisation test for identifying "Streptococcus milleri group".
    Whitworth JM; Ross PW; Poxton IR
    J Clin Pathol; 1991 Apr; 44(4):329-33. PubMed ID: 2030154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Fc(gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri".
    Lebrun L; Guibert M; Wallet P; de Maneville MM; Pillot J
    J Clin Microbiol; 1986 Nov; 24(5):705-7. PubMed ID: 3771760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics.
    Jacobs JA; Pietersen HG; Stobberingh EE; Soeters PB
    Am J Clin Pathol; 1995 Nov; 104(5):547-53. PubMed ID: 7572815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of beta-hemolytic streptococci from the respiratory tract: distribution and clinical significance.
    Ekenna O; Verghese A; Karnad A; Basile P; Berk SL
    Am J Med Sci; 1988 Feb; 295(2):94-101. PubMed ID: 3344761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serogroup distribution and antimicrobial susceptibility of beta-hemolytic streptococci in clinical isolates.
    Srifuengfung S; Gherunpong V; Nimrat S
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):139-43. PubMed ID: 7825004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lancefield grouping and smell of caramel for presumptive identification and assessment of pathogenicity in the Streptococcus milleri group.
    Brogan O; Malone J; Fox C; Whyte AS
    J Clin Pathol; 1997 Apr; 50(4):332-5. PubMed ID: 9215152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presumptive identification of "Streptococcus milleri" in 5 h.
    Ruoff KL; Ferraro MJ
    J Clin Microbiol; 1986 Sep; 24(3):495-7. PubMed ID: 3760146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the Streptococcus milleri group in peritonsillar abscesses].
    Fujiyoshi T; Inaba T; Udaka T; Tanabe T; Yoshida M; Makishima K
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):866-71. PubMed ID: 11605227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.
    Ruoff KL
    Clin Microbiol Rev; 1988 Jan; 1(1):102-8. PubMed ID: 3060239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and incidence of viridans streptococcal species in routine clinical specimens.
    Ruoff KL; Fishman JA; Calderwood SB; Kunz LJ
    Am J Clin Pathol; 1983 Dec; 80(6):854-8. PubMed ID: 6637890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on streptococci resembling Streptococcus milleri and on an associated surface-protein antigen.
    Lütticken R; Wendorff U; Lütticken D; Johnson EA; Wannamaker LW
    J Med Microbiol; 1978 Nov; 11(4):419-31. PubMed ID: 82618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid differentiation of Streptococcus milleri from other beta-haemolytic group A, C, and G streptococci by simple screening tests.
    O'Neill WA; Cooke RP
    Br J Biomed Sci; 1994 Mar; 51(1):1-4. PubMed ID: 7841829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.
    Salavert M; Gómez L; Rodriguez-Carballeira M; Xercavins M; Freixas N; Garau J
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):365-71. PubMed ID: 8793393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
    Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
    Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and pathogenicity of the Streptococcus milleri group.
    Gossling J
    Rev Infect Dis; 1988; 10(2):257-85. PubMed ID: 3287560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Streptococcus milleri and Streptococcus mitior from infected dental root canals.
    Mejàre B
    Odontol Revy; 1975; 26(4):291-308. PubMed ID: 1061026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and biological characteristics of "Streptococcus milleri" isolates from systemic purulent infections.
    Kitada K; Nagata K; Yakushiji T; Eifuku H; Inoue M
    J Med Microbiol; 1992 Mar; 36(3):143-8. PubMed ID: 1548688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and bacteriological significance of the Streptococcus milleri group in deep neck abscesses].
    Fujiyoshi T; Okasaka T; Yoshida M; Makishima K
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Feb; 104(2):147-56. PubMed ID: 11257779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.